Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/174239
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Blanco Arbués, Julià | - |
dc.contributor.author | Sarukhan, Adelaida | - |
dc.contributor.author | Díez Antón, Juana, 1962- | - |
dc.contributor.author | Bassat Orellana, Quique | - |
dc.contributor.author | Campins Martí, Magda | - |
dc.contributor.author | Güerri Fernández, Robert | - |
dc.contributor.author | Brotons, Carlos | - |
dc.contributor.author | Sans Corrales, Mireia | - |
dc.contributor.author | Miró Meda, José M. | - |
dc.contributor.author | Sanjosé Llongueras, Silvia de | - |
dc.date.accessioned | 2021-02-24T11:30:18Z | - |
dc.date.available | 2021-02-24T11:30:18Z | - |
dc.date.issued | 2021-02-24 | - |
dc.identifier.uri | http://hdl.handle.net/2445/174239 | - |
dc.description | Additional support from ISGlobal’s Antoni Plasència and Josep M. Antó | - |
dc.description.abstract | As the COVID-19 pandemic progresses, so does our knowledge of the magnitude, type and durability of the immune response to SARS-CoV-2 as a result of natural infection or vaccination. This information is crucial since it will largely define the strategies we need to implement in order to protect individuals and populations. With this in mind, the GCMSC presents its second report, where they review the current knowledge on immunity to SARS-CoV-2 and the implications in terms of public health policies. | ca |
dc.format.extent | 37 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | ca |
dc.publisher | Institut de Salut Global de Barcelona (ISGlobal) | ca |
dc.publisher | Col·legi Oficial de Metges de Barcelona (COMB) | - |
dc.rights | cc-by (c) Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC), 2021 | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
dc.source | Documents de treball / Informes (ISGlobal) | - |
dc.subject.classification | COVID-19 | - |
dc.subject.classification | Vacunes | - |
dc.subject.classification | Immunitat | - |
dc.subject.classification | Salut pública | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | Vaccines | - |
dc.subject.other | Immunity | - |
dc.subject.other | Public health | - |
dc.title | What do we know about Immunity to SARS-CoV-2? Implications for Public Health Policies | ca |
dc.type | info:eu-repo/semantics/report | ca |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
Appears in Collections: | Documents de treball / Informes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Report Immunity to SARS CoV2.pdf | 668.98 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License